Delta-24-RGDOX (DNX-2440), an improved version of Delta-24-RGD, stimulates immunostimulating OX40 ligand (OX40L) expression on infected tumor cells, activating T cells recognizing tumor cell antigens. This evidence concerns the gene TNFSF4 and neoplasm.